TC SYNAPSE
DEAD

Serial Number

87780307

Owner

TrialCard Incorporated

Attorney

Larry L. Coats

First Use Date

May 22, 2018

Filing Date

Feb 1, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TC SYNAPSE Trademark

Serial Number: 87780307 • Registration: 5729255

TC SYNAPSE is a trademark filed by TrialCard Incorporated on February 1, 2018. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

TrialCard Incorporated (22 trademarks)

6501 Weston Parkway
Cary, NC 27513

Entity Type: 03

MERCALIS INC. (19 trademarks)

2250 PERIMETER PARK DRIVE
MORRISVILLE, NC 275608893

Entity Type: 03

Trademark Details

Filing Date

February 1, 2018

Registration Date

April 16, 2019

First Use Anywhere

May 22, 2018

First Use in Commerce

May 22, 2018

Published for Opposition

December 4, 2018

Cancellation Date

October 31, 2025

Goods & Services

pharmacy benefit manager (PBM) accumulator mitigation services and detecting claim activity indicative of a pharmacy benefit manager attempting to abuse the use of co-pay cards by not applying amounts paid by clients towards the patient's deductible or annual out-of-pocket expense; anti-kickback and risk mitigation services for the pharmaceutical industry, namely, anti-kickback compliance services for assuring that patients who have full or partial federally funded drug coverage are excluded from utilizing co-pay cards

data management services in the field of pharmaceutical patient safety, namely, collecting adverse events data; storing the data; and reporting collected adverse events data

quality assurance and quality control patient claim services for monitoring paid claims to patients from insurance or pharmaceutical entities to insure that specific business rules are being correctly applied to patient claims; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; pharmacovigilance services for others, namely, monitoring the quality of efficacy of pharmaceutical preparations

legislative update services and updating legal and regulatory issues within the co-pay or patient affordability space; pharmacy fraud monitoring services

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 31, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 16, 2024 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 15, 2023 ASGN
REGISTERED-PRINCIPAL REGISTER
Apr 16, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 13, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 12, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 21, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 21, 2019 AITU
USE AMENDMENT FILED
Jan 30, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 30, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 29, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 4, 2018 NPUB
PUBLISHED FOR OPPOSITION
Dec 4, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 14, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 1, 2018 PREV
ASSIGNED TO LIE
Oct 31, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 17, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 3, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 3, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 3, 2018 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2018 NWOS
NEW APPLICATION ENTERED
Feb 5, 2018 NWAP